Articles

Poll

Podcasts

Slideshows

Videos

Electronic health interventions improved medication adherence in kidney transplant recipients, with potential implications for improving patient outcomes.

Electronic Health Interventions Improve Post-Kidney Transplant Medication Adherence

Study findings suggest significant socioeconomic disparities in preemptive kidney transplantation rates in children and the need for targeted interventions.

Socioeconomic Status Impacts Pediatric Preemptive Kidney Transplant Rates, Study Finds

Our Q1 recap for nephrology spotlights regulatory updates, new clinical trial data, and advancements in xenotransplant.

Q1 2025 Recap: Nephrology News and Updates

Data from nearly half a dozen trials suggests steroidal MRAs may provide little benefit in kidney transplant patients.

Steroidal MRAs Provide Little Benefit, Increase Hyperkalemia Risk in Kidney Transplant Patients

Our top 5 headlines featured key FDA moves in nephrology and ophthalmology, from new approvals to trial terminations and priority reviews.

The HCPFive: Top News for Healthcare Providers from the Week of 03/30

Using CURE-CKD Registry data, the analysis showed relatively rapid-onset CKD was common in people with prediabetes, especially with hypertension or ASCVD.

CKD Common in Patients with Prediabetes, Especially with Hypertension or ASCVD

The approval indicates Novartis's atrasentan (Vanrafia) for proteinuria reduction in primary IgA nephropathy.

Atrasentan (Vanrafia) Receives Accelerated Approval in IgA Nephropathy

The March 2025 month in review spotlights a new episode of Crisis Point about CKD for National Kidney Month and renal FDA news.

Nephrology Month in Review: March 2025

Study findings suggest COVID-19 is linked to a greater risk of long-term kidney dysfunction and new-onset advanced CKD than influenza.

COVID-19 Infection Increases Risk of Advanced CKD, Long-Term Renal Dysfunction

The first quarter of 2025 saw approvals in diabetes, depression, kidney disease, and pain, among others. Read more about high-impact approvals of Q1 now.

Top 5 FDA Approvals from Q1 2025

C3 Glomerulopathy

The HCPLive C3 glomerulopathy page is a resource for medical news and expert insights on C3G. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in C3G, and more.

IgA Nephropathy

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Focal Segmental Glomerulosclerosis

The HCPLive focal segmental glomerulosclerosis page is a resource for medical news and expert insights on FSGS. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in FSGS, and more. 

Chronic Kidney Disease

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.